These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation. Uprichard AC; Allen JD; Harron DW J Cardiovasc Pharmacol; 1988 Feb; 11(2):235-41. PubMed ID: 2452320 [TBL] [Abstract][Full Text] [Related]
25. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide. Pottage A Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279 [TBL] [Abstract][Full Text] [Related]
26. Randomized double-blind study of intravenous tocainide versus lidocaine for suppression of ventricular arrhythmias after cardiac surgery. Manolis AS; Smith E; Payne D; Rastegar H; Cleveland R; Estes NA Clin Cardiol; 1990 Mar; 13(3):177-81. PubMed ID: 2108835 [TBL] [Abstract][Full Text] [Related]
27. Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias. Nestico PF; DePace NL; Morganroth J Med Clin North Am; 1984 Sep; 68(5):1295-319. PubMed ID: 6436595 [TBL] [Abstract][Full Text] [Related]
28. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin]. Witkowska M Kardiol Pol; 1981; 24(11-12):803-13. PubMed ID: 6804681 [No Abstract] [Full Text] [Related]
29. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery. Morganroth J; Panidis IP; Harley S; Johnson J; Smith E; MacVaugh H Am J Cardiol; 1984 Dec; 54(10):1253-8. PubMed ID: 6439023 [TBL] [Abstract][Full Text] [Related]
30. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine. Snyder DW J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645 [TBL] [Abstract][Full Text] [Related]
32. Long-term tocainide therapy for ventricular arrhythmias. Winkle RA; Meffin PJ; Harrison DC Circulation; 1978 May; 57(5):1008-16. PubMed ID: 639200 [TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacokinetics of the newer antiarrhythmic agents. Gillis AM; Kates RE Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study. Mahapatra RK; Mahapatra D Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347 [TBL] [Abstract][Full Text] [Related]
35. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165. Hashimoto K; Ishii M; Komori S; Mitsuhashi H Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304 [TBL] [Abstract][Full Text] [Related]
36. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing. Murray KT; Barbey JT; Kopelman HA; Siddoway LA; Echt DS; Woosley RL; Roden DM Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025 [TBL] [Abstract][Full Text] [Related]
37. Tocainide in the cardiac ICU. Benning CA; Burke PA Crit Care Nurse; 1989 Feb; 9(2):45-53. PubMed ID: 2510974 [No Abstract] [Full Text] [Related]